APA (7th ed.) Citation

Dailey, K. M., Small, J. M., Pullan, J. E., Winfree, S., Vance, K. E., Orr, M., . . . Brooks, A. E. (2023). An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic. PLoS ONE, 18(11), 1. https://doi.org/10.1371/journal.pone.0289183

Chicago Style (17th ed.) Citation

Dailey, Kaitlin M., et al. "An Intravenous Pancreatic Cancer Therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium Novyi-Non Toxic." PLoS ONE 18, no. 11 (2023): 1. https://doi.org/10.1371/journal.pone.0289183.

MLA (9th ed.) Citation

Dailey, Kaitlin M., et al. "An Intravenous Pancreatic Cancer Therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium Novyi-Non Toxic." PLoS ONE, vol. 18, no. 11, 2023, p. 1, https://doi.org/10.1371/journal.pone.0289183.